Quick Asked: Oncimmune Contact Us?

Are you searching for Oncimmune Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 30 Mar, 2024 211 Views

What is oncimmunes technology? The company’s proprietary technology platform, EarlyCDT® is extensively validated for all types of lung cancer and for hepatocellular carcinoma (liver cancer). Oncimmune is helping to lead the advancement of early cancer detection across a range of solid tumour types.

Why oncimmune immunoinsights? Oncimmune’s ImmunoINSIGHTS platform enables life-science organisations to optimise drug development and delivery, leading to more effective targeted as well as safer treatments for patients. Oncimmune's immunodiagnostic technology, EarlyCDT, can detect and help identify cancer on average four years earlier than standard clinical diagnosis.

What is oncimmunes collaboration with roche and university medical center utrecht? Oncimmune's collaboration with Roche and University Medical Center Utrecht demonstrates the utility of autoantibodies in methotrexate and tocilizumab treatment selection. “By backing this pioneering project, we are ensuring that the best therapeutic approaches can be offered to the right patients at the right time.”

How can i contact immuneti customer support? We'd love to hear from you. The Immuneti team is always available to provide the best in customer support. Please fill out the form or email us directly at [email protected] . For press related inquiries please contact [email protected] .

Listing Results Oncimmune Contact Us? Question Answers

NOMAD & advisor contacts Oncimmune

Investors Oncimmune

Oncimmune's immunodiagnostic technology, EarlyCDT, can detect and help identify cancer on average four years earlier than standard clinical diagnosis. Our lead diagnostic test, EarlyCDT Lung, targets a vast market estimated to grow to £3.8bn by 2024. With over 200,000 tests already performed for patients worldwide and its use being supported

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.